Oxurion N.V.

Oxurion N.V.

TBGNF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$208.95K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Oxurion N.V.Oxurion N.V.0-11%--0.9

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$208,946.00
Enterprise Value$11.69 Million
Earnings per Share$0.09
Beta0.35
Outstanding Shares1,229,096

Return

Return on Equity11.13%ROE
Return on Assets-43.67%
Return on Invested Capital12.08%

Valuation & Multiples

P/E Ratio-0.01P/E Ratio
PEG0.05PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.02Price to Book Ratio
Enterprise Value to Revenue10.18
Enterprise Value to EBIT-7.47
Enterprise Value to Net Income-8
Total Debt to Enterprise0.98
Debt to Equity-0.85Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Oxurion N.V.

26 employees
CEO: Pascal Ghoson

Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized...